WHWK: Aadi Bioscience Inc Price/Earnings to Growth Multiple

Symbol and logo of brand Aadi Bio (WHWK)

The GURU.Markets portal provides the P/E ratio and growth rates for Aadi Bioscience Inc (WHWK), where the 0.00 metric reflects current dynamics. This authoritative developer of targeted drugs for rare forms of cancer enjoys the trust of physicians. The company integrates ESG principles into therapy development while adhering to testing ethics. Drug production relies entirely on external GMP contractors under long-term agreements.

Price/Earnings to Growth Ratio: Aadi Bioscience, Inc. (WHWK) for 03/20/2025 - 11/10/2026

Analytical breakdowns for Aadi Bioscience Inc (WHWK)

- share price and consensus valuation forecast:
Price Performance Chart aadibio.com|WHWK - Analyst Consensus Forecast
- market capitalization information:
Market Valuation Aadi Bio|WHWK - Real Price to Acquire Entire Company
- book value of equity indicators:
Book Value per Share Aadi Bioscience|WHWK - Company Book Value|Market Value to Book Value aadibio.com|WHWK - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Aadi Bioscience Inc|WHWK - Long-Term Debt to Capital|Short-Term Debt to Capital aadibio.com|WHWK - Company Aggregate Debts|Debts to Book Capitalization Aadi Bio|WHWK - Company Long-Term Debts|Company Short-Term Indebtedness Aadi Bioscience|Interim Coverage Ratio aadibio.com
- company profitability and valuation multiples indicators:
WHWK - Net Income|Expected Net Income Aadi Bioscience Inc|WHWK - P/E Multiple|Future Price to Earnings aadibio.com|WHWK - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aadi Bio|WHWK - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Aadi Bioscience|WHWK - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months aadibio.com|WHWK - Earnings growth in current year|Expected earnings per share growth for next year Aadi Bioscience Inc
General company analysis:WHWK Aadi Bioscience, Inc.
Mass-produced product of Aadi Bioscience Inc

Aadi Bioscience Inc (WHWK) operates automated logistics hubs and fully utilized oncology drug production capacities. This indicator compares the current P/E ratio with expected earnings growth to identify undervalued assets. Investors seek values below one to find potentially high-growth stocks. However, sharp drawdowns necessitate caution due to liquidity risks. By analyzing the calculated PEG ratio, one can assess the efficiency of the business scaling.

Competing companies

ONC (BeiGene Ltd.) - Growth-Adjusted Payback Ratio|PEG Multiple HALO (Halozyme Inc.)|RVMD - Price/Earnings to Growth Multiple|AAPG: Price/Earnings to Growth Multiple|CGON - PEG Multiple|UroGen Pharma (URGN) - Price/Earnings to Growth Ratio|Bicara Therapeutics Inc - Growth-Adjusted Payback Ratio|PSNL (Personalis Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Erasca Oncology ERAS|PEG Multiple DCTH|PEG Multiple ymabs.com (YMAB)|PEG Multiple AURA (Aura Biosciences)|PEG Multiple Candel Therapeutics Inc. CADL|Accuray Inc. - PEG Multiple|SLS (SELLAS Life Sciences) - Growth-Adjusted P/E Ratio|ACTU: PEG Multiple|CTOR - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple HURA|TARA: Growth-Adjusted Payback Ratio|PEG Multiple FATE|Price/Earnings to Growth Ratio TCRX (tscan.com)|PEG Multiple CSBR (Champions Oncology, Inc.)|Growth-Adjusted Market Cap to Net Income XBiotech Inc (XBIT)|CVM - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate OS Therapies Inc.|Radiopharm Theranostics Limited (RADX) - Price/Earnings to Growth Ratio|ARTV - Growth-Adjusted Market Cap to Net Income|ANL (Adlai Nortye Ltd) - PEG Multiple|Price/Earnings to Growth Multiple verupharma.com (VERU)|PEG Multiple TPST|Growth-Adjusted Market Cap to Net Income xiliotx.com|PEG Multiple RENB (Renovaro)|Mural Oncology PLC (MURA) - Price to Earnings Adjusted for Growth Rate|KAPA - Price/Earnings to Growth Ratio|OKUR (OnKure Therapeutics Inc) - Growth-Adjusted P/E Ratio|GDTC: PEG Multiple|Price/Earnings to Growth Multiple Curis|APLM (Apollomics Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Tharimmune Corporation THAR|Price/Earnings to Growth Multiple ADVB (Advanced Biomed Inc)|GNPX (genprex.com) - Growth-Adjusted Payback Ratio|PEG Multiple CLDI (Calidi Biotherapeutics, Inc.)|Growth-Adjusted Market Cap to Net Income Sunshine Biopharma Inc. (SBFM)|XBIO - Price/Earnings to Growth Ratio|SLRX (Salarius Pharma) - Growth-Adjusted P/E Ratio|PPBT: PEG Multiple|Price/Earnings to Growth Multiple American Oncology Network, Inc.|Price/Earnings to Growth Multiple BGNE|Price/Earnings to Growth Multiple Checkpoint Therapeutics Inc. (CKPT)|PEG Multiple ELEV|ICAD (icadmed.com) - Growth-Adjusted Payback Ratio|Ikena Oncology - Price/Earnings to Growth Multiple|NTBL - Price/Earnings to Growth Multiple|VIRX - Price/Earnings to Growth Ratio|MOR - PEG Multiple|NAYA: PEG Multiple|Price/Earnings to Growth Multiple Ascentage